Inventor · disambiguated record
Kandavel Shanmugam
Also filed as: SHANMUGAM KANDAVEL
10 granted patents·8 pending applications·20 citations·filing 2016–2024
84Inventor score
Files withVENTANA MED SYST INC18
Top patents by PatentIndex Score
18 records- 0195US11663717B2Methods, systems, and apparatuses for quantitative analysis of heterogeneous biomarker distributionVENTANA MED SYST INC·Filed 2021·Granted May 30, 2023·13 cites·13 claims
- 0287US10852304B2Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulinVENTANA MED SYST INC·Filed 2017·Granted Dec 1, 2020·3 cites·19 claims
- 0384US10664967B2Methods, systems, and apparatuses for quantitative analysis of heterogeneous biomarker distributionVENTANA MED SYST INC·Filed 2017·Granted May 26, 2020·4 cites·20 claims
- 0484US2025054144A1Methods and systems for evaluation of immune cell infiltrate in tumor samplesVENTANA MED SYST INC·Filed 2024·Application pending·0 cites
- 0582US12419201B2Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulinVENTANA MED SYST INC·Filed 2023·Granted Sep 23, 2025·0 cites·25 claims
- 0682US12154275B2Methods and systems for evaluation of immune cell infiltrate in tumor samplesVENTANA MED SYST INC·Filed 2023·Granted Nov 26, 2024·0 cites·31 claims
- 0774US11783478B2Methods and systems for evaluation of immune cell infiltrate in tumor samplesVENTANA MED SYST INC·Filed 2022·Granted Oct 10, 2023·0 cites·13 claims
- 0871US11747339B2Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulinVENTANA MED SYST INC·Filed 2020·Granted Sep 5, 2023·0 cites·20 claims
- 0968US11250566B2Methods and systems for evaluation of immune cell infiltrate in tumor samplesVENTANA MED SYST INC·Filed 2020·Granted Feb 15, 2022·0 cites·35 claims
- 1065US11049247B2Methods, systems, and apparatuses for quantitative analysis of heterogeneous biomarker distributionVENTANA MED SYST INC·Filed 2020·Granted Jun 29, 2021·0 cites·20 claims
- 1159US2023204585A1Histochemical systems and methods for evaluating egfr and egfr ligand expression in tumor samplesVENTANA MED SYST INC·Filed 2022·Application pending·0 cites
- 1259US2025093356A1Methods and systems for predicting response to pd-1 axis directed therapeutics in colorectal tumors with deficient mismatch repairVENTANA MED SYST INC·Filed 2024·Application pending·0 cites
- 1358US2023280345A1Prediction of response to epidermal growth factor receptor-directed therapies using epiregulin and amphiregulinVENTANA MED SYST INC·Filed 2023·Application pending·0 cites
- 1455US2024046473A1Transformation of histochemically stained images into synthetic immunohistochemistry (ihc) imagesVENTANA MED SYST INC·Filed 2023·Application pending·0 cites
- 1548US12422435B2Methods and systems for evaluation of immune cell infiltrate in stage III colorectal cancerVENTANA MED SYST INC·Filed 2020·Granted Sep 23, 2025·0 cites·46 claims
- 1645US2021373024A1Methods and systems for evaluation of immune cell infiltrate in stage iv colorectal cancerVENTANA MED SYST INC·Filed 2021·Application pending·0 cites
- 1740US2019269716A1Compositions and methods for prognosing and treating colorectal cancerVENTANA MED SYST INC·Filed 2019·Application pending·0 cites
- 1831US2017038385A1G-Alpha Interacting Vesicle Associated Protein (GIV) as a Predictive Marker in Stage II Colorectal CancerVENTANA MED SYST INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kandavel Shanmugam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →